Apellis Pharmaceuticals, Inc. (APLS)
20.31
-0.39
(-1.88%)
USD |
NASDAQ |
Mar 03, 13:10
Apellis Pharmaceuticals Shareholders Equity (Quarterly) : 370.15M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -80.00M |
| Amneal Pharmaceuticals, Inc. | -70.79M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Amicus Therapeutics, Inc. | 274.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.075B |
| Total Liabilities (Quarterly) | 705.11M |
| Debt to Equity Ratio | 1.282 |
| Current Ratio | 3.136 |
| Net Debt Paydown Yield | -0.02% |